Variable | Survivors (n = 116) | Non-survivors (n = 49) | P value |
---|---|---|---|
Age | 57.8 ± 17.9 | 61 ± 16.4 | 0.297 |
Male gender | 75(64.7) | 35(71.4) | 0.399 |
American Society of Anaesthesiologists (ASA) score | |||
1 | 13(11.2) | 5(10.2) | 0.268 |
2 | 33(28. 5) | 10(20.4) | |
3 | 50(43.1) | 19(38. 8) | |
4 | 20(17.2) | 15(30.6) | |
Pre-existing medical conditions | |||
Diabetes mellitus | 60(51.7) | 24(49.0) | 0.747 |
Hypertension | 39(33.6) | 20(41. 7) | 0.329 |
Chronic renal failure | 17(14.7) | 12(24.5) | 0.129 |
Liver cirrhosis | 13(11.2) | 9(18.4) | 0.216 |
Malignancy | 10(8.6) | 4(8.2) | 1 |
Immunosuppresant medication | 9(7.8) | 6(12.2) | 0.382 |
Admission lab data | |||
Hemoglobin (mg/dl) | 10.8 ± 2.4 | 10.1 ± 2.6 | 0.135 |
Leukocyte count (103/mm3) | 11.3 ± 11.3 | 9.7 ± 9.9 | 0.3777 |
Platelet count (103/mm3) | 193.7 ± 128.8 | 135.2 ± 89.0 | 0.0021 |
C-reactive protein > 10 mg/dla | 58(79. 5) | 29(78.4) | 0896 |
Glucose > 110 mg/dlb | 39(65) | 19(82.61) | 0.356 |
Potassium (mEq/l) | 4.0 ± 0.9 | 4.5 ± 1.2 | 0.034 |
Positive blood culturec | 33(38.82) | 22(59.46) | 0.035 |
Location of infection | |||
body | 9(7.8) | 12(24.5) | 0.025 |
head and neck | 3(2.6) | 1(2.0) | |
upper limb | 10(8.6) | 7(14.3) | |
lower limb | 84(72.4) | 27(55.1) | |
multiple sites | 10(8.6) | 2(4.1) | |
Time to surgery <12 h | 62(54.39) | 25(54.35) | 0.531 |
ICU stay (day) | 9.5 ± 12.1 | 9.5 ± 10.4 | 0.977 |
Hospital stay (day) | 51.7 ± 33.4 | 13.6 ± 14.4 | <.0001 |
Limb loss | 28(24.1) | 7(14.3) | 0.157 |